Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP179508.RABg2KCQ3OvN7T50ISiLODA5xxmCIoo1fkn9n_IWMKEcQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP179508.RABg2KCQ3OvN7T50ISiLODA5xxmCIoo1fkn9n_IWMKEcQ130_assertion type Assertion NP179508.RABg2KCQ3OvN7T50ISiLODA5xxmCIoo1fkn9n_IWMKEcQ130_head.
- NP179508.RABg2KCQ3OvN7T50ISiLODA5xxmCIoo1fkn9n_IWMKEcQ130_assertion description "[expression of VEGFR-3 (S) is up-regulated in > 75% of hepatitis B x antigen positive hepatocellular carcinoma (HCC) nodules; HBxAg may short circuit VEGFR-3 (S) signaling in liver cancer]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP179508.RABg2KCQ3OvN7T50ISiLODA5xxmCIoo1fkn9n_IWMKEcQ130_provenance.
- NP179508.RABg2KCQ3OvN7T50ISiLODA5xxmCIoo1fkn9n_IWMKEcQ130_assertion evidence source_evidence_literature NP179508.RABg2KCQ3OvN7T50ISiLODA5xxmCIoo1fkn9n_IWMKEcQ130_provenance.
- NP179508.RABg2KCQ3OvN7T50ISiLODA5xxmCIoo1fkn9n_IWMKEcQ130_assertion SIO_000772 17539024 NP179508.RABg2KCQ3OvN7T50ISiLODA5xxmCIoo1fkn9n_IWMKEcQ130_provenance.
- NP179508.RABg2KCQ3OvN7T50ISiLODA5xxmCIoo1fkn9n_IWMKEcQ130_assertion wasDerivedFrom lhgdn-20090331 NP179508.RABg2KCQ3OvN7T50ISiLODA5xxmCIoo1fkn9n_IWMKEcQ130_provenance.
- NP179508.RABg2KCQ3OvN7T50ISiLODA5xxmCIoo1fkn9n_IWMKEcQ130_assertion wasGeneratedBy ECO_0000203 NP179508.RABg2KCQ3OvN7T50ISiLODA5xxmCIoo1fkn9n_IWMKEcQ130_provenance.